These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35818742)

  • 21. Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro.
    Hasegawa T; Hara K; Hata S
    Drug Metab Dispos; 1994; 22(3):377-82. PubMed ID: 8070313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting.
    Barnebey H; Kwok SY
    Clin Ther; 2000 Oct; 22(10):1204-12. PubMed ID: 11110231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
    Ormrod D; McClellan K
    Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High resolution full scan liquid chromatography mass spectrometry comprehensive screening in sports antidoping urine analysis.
    Abushareeda W; Vonaparti A; Saad KA; Almansoori M; Meloug M; Saleh A; Aguilera R; Angelis Y; Horvatovich PL; Lommen A; Alsayrafi M; Georgakopoulos C
    J Pharm Biomed Anal; 2018 Mar; 151():10-24. PubMed ID: 29291455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial assessing dorzolamide in patients with glaucoma who are younger than 6 years.
    Ott EZ; Mills MD; Arango S; Getson AJ; Assaid CA; Adamsons IA
    Arch Ophthalmol; 2005 Sep; 123(9):1177-86. PubMed ID: 16157797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination profile of low-dose chlortalidone and its detection in hair for doping analysis-Implication for unintentional non-therapeutic exposure.
    Thieme D; Weigel K; Anielski P; Krumbholz A; Sporkert F; Keiler AM
    Drug Test Anal; 2024 Feb; ():. PubMed ID: 38374541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma.
    Avunduk AM; Sari A; Akyol N; Oztürk O; Kapicioglu Z; Erdöl H; Imamoglu HI
    Ophthalmologica; 2001; 215(5):361-5. PubMed ID: 11528262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
    Chiseliţă D; Antohi I; Medvichi R; Danielescu C
    Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients.
    Arend O; Harris A; Wolter P; Remky A
    Acta Ophthalmol Scand; 2003 Oct; 81(5):474-9. PubMed ID: 14510794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1998 Oct; 105(10):1936-44. PubMed ID: 9787367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.
    Hartenbaum D; Maloney S; Vaccarelli L; Liss C; Wilson H; Gormley GJ
    Clin Ther; 1999 Sep; 21(9):1533-8. PubMed ID: 10509848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination and characterization of diuretics in human urine by liquid chromatography coupled to pneumatically assisted electrospray ionization mass spectrometry.
    Sanz-Nebot V; Toro I; Bergés R; Ventura R; Segura J; Barbosa J
    J Mass Spectrom; 2001 Jun; 36(6):652-7. PubMed ID: 11433538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ability of dorzolamide hydrochloride and timolol maleate to target mitochondria in glaucoma therapy.
    Saccà SC; La Maestra S; Micale RT; Larghero P; Travaini G; Baluce B; Izzotti A
    Arch Ophthalmol; 2011 Jan; 129(1):48-55. PubMed ID: 21220628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients.
    Kouchak M; Malekahmadi M; Bavarsad N; Saki Malehi A; Andishmand L
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1239-1242. PubMed ID: 28956449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.
    Simmons ST;
    Clin Ther; 2001 Apr; 23(4):604-19. PubMed ID: 11354394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE; Ghosh K; Gieser DK; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.